Observational Epidemiologic Study in Women With Premature Ovarian Failure (POF)
NCT ID: NCT02068976
Last Updated: 2022-05-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2013-11-28
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
iPOI (Investigators in premature ovarian insufficiency): M. Guinot, B. Roca, J. Tomás, P. Escamilla, J. Hernández, P. Llaneza, N. Mendoza Ladrón de Guevara, B. Otero García, I. Ñiguez, A. Castro, L. Baquedano, P. Romero, S. Sánchez.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Premature Ovarian Failure (Genetic and Physiopathologic Analysis)
NCT00780897
Investigation of Copy Number Variations and Genetic Variants in POI
NCT05327283
Assessment of Ovarian Reserve in Patients With Fragile X Premutation
NCT07039734
Genetic Analysis of Familial Cases of Premature Ovarian Failure
NCT01177891
Women's Experience of Premature Ovarian Insufficiency (POI) Diagnosis: Update on Actual Practices and Patient's Follow up
NCT06228547
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with Primary Ovarian Insufficiency
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary ovarian insufficiency demonstrated with amenorrhea and levels of follicle stimulating hormone (FSH) over to 40 IU in two determinations measured with a difference of one moth.
* Not present linguistic barriers ,shaw attitude towards collaboration ,be able to attend the study center for all follow-up visits.
* Signed informed consent before inclusion in the study and after having been informed of the procedures performed in this study.
Exclusion Criteria
* Refusal to participate.
* Withdrawal of informed consent.
18 Years
39 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Misericordia Guinot, MD PhD
Role: STUDY_CHAIR
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitari General de Catalunya
Sant Cugat del Vallès, Barcelona, Spain
Hospital Universitario Materno Infantil de Canarias
Las Palmas de Gran Canaria, Las Palmas, Spain
Hospital de Manacor
Manacor, Palma de Mallorca, Spain
Hospital Universitario Central de Asturias
Oviedo, Principality of Asturias, Spain
Hospital de Poniente de El Egido
Almería, , Spain
Complejo Asistencial de Avila
Ávila, , Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, , Spain
Hospital Terrasa
Barcelona, , Spain
Hospital Universitari Mutua de Terrasa
Barcelona, , Spain
Hospital Universitario de Cruces
Bilbao, , Spain
Hospital Universitario Virgen de las Nieves
Granada, , Spain
Universidad de Granada
Granada, , Spain
Grupo Hospitalario Perpetuo Socorro
Lleida, , Spain
HCU Virgen de la Arrixaca
Murcia, , Spain
Hospital Universitario Miguel Servet
Zaragoza, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Sonia Sánchez, MD
Role: primary
Patricia Escamilla, MD
Role: primary
Placido Llaneza, MD
Role: primary
Pablo Romero, MD
Role: primary
Ana Castro, MD
Role: primary
Beatriz Roca, MD
Role: primary
Jordi Tomas, MD
Role: primary
Borja O Garcia Ramos, MD
Role: primary
Jorge Fernandez, MD
Role: primary
Nicolas Mendoza Ladron de Guevara, MD
Role: primary
Marta Canals, MD
Role: primary
Isabel Ñiguez, MD
Role: primary
Laura Baquedano, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IIBSP-IOP-2012-109
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.